Immunological classification of acute myeloblastic leukemias: relevance to patient outcome

@article{Casasnovas2003ImmunologicalCO,
  title={Immunological classification of acute myeloblastic leukemias: relevance to patient outcome},
  author={R O Casasnovas and Fouad Slimane and Richard Garand and Gilbert Charles Faure and Lydia Campos and V{\'e}ronique Deneys and Michel Bernier and Annie Falkenrodt and G Lecalvez and Marck Maynadi{\'e} and Marie Christine B{\'e}n{\'e}},
  journal={Leukemia},
  year={2003},
  volume={17},
  pages={515-527}
}
Immunophenotyping is a major tool to assign acute leukemia blast cells to the myeloid lineage. However, because of the large heterogeneity of myeloid-related lineages, no clinically relevant immunological classification of acute myeloblastic leukemia (AML) has been devised so far. To attempt at formulating such a classification, we analyzed the pattern of expression of selected antigens, on blast cells collected at AML diagnosis. Patients were eligible if they had a first diagnosis of de novo… CONTINUE READING